Author

James Campbell

The Francis Crick InstituteORCID 0000-0001-6756-8766Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

James Campbell2 papers · University of Kentucky

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Alicia Alonso de la VegaiD· 1 shared Andrea de CastroiD· 1 shared Ania Mikolajczak· 1 shared Christopher Moore· 1 shared Claire E. PillsburyiD· 1 shared Julian DownwardiD· 1 shared KangBo NgiD· 1 shared Míriam Molina‐ArcasiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alicia Alonso de la VegaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintOct 27, 2025

Leveraging death of drug-sensitive cancer cells to promote immune-mediated bystander killing of subclones of drug-resistant tumor cells

Mona Tomaschko, KangBo Ng, Christopher Moore…·Julian Downward

This study shows that targeting drug-sensitive cancer cells with G12Ci inhibitors and combining it with immune therapies can eliminate drug-resistant subclones through immune-mediated bystander killing.

DOI 10.1101/2025.10.27.684825

mouseexperimental assay

𝕏 PostBluesky